CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced Hodgkin's lymphoma patients in china trial
Disease control OngoingThis study is testing whether adding a new immunotherapy drug called camrelizumab to standard chemotherapy (AVD) works better for people with advanced Hodgkin's lymphoma who haven't had treatment before. The trial will enroll 60 patients to see if this combination helps more peop…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Pfizer tests new cancer drug combo in early human trial
Disease control OngoingThis early-stage study is testing the safety of a new cancer drug called PF-08046032, both by itself and combined with another drug called sasanlimab. It involves a small group of adults with advanced or spreading cancers, including certain lymphomas and solid tumors like lung ca…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Two-Drug attack tested for Tough-to-Treat Hodgkin's lymphoma
Disease control OngoingThis study is testing whether combining two drugs, ibrutinib and nivolumab, can help control classical Hodgkin's lymphoma that has returned or hasn't responded to previous treatments. The trial involves 18 adults who have already had at least one prior therapy. Researchers want t…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC